September 23, 2014 4:25 AM ET

Healthcare Equipment and Supplies

Company Overview of Angiotech Pharmaceuticals Inc.

Executive Profile

Jeffrey D. Goldberg

Co-Chairman of the Board and Chairman of Governance, Nominating & Compensation Committee, Angiotech Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 0 different industries.

See Board Relationships
48--

Background

Mr. Jeffrey D. Goldberg, also known as Jeff, serves as the President of IncuMed. Mr. Goldberg serves as the Chief Executive Officer of RoundTrip Technologies (tagging, tracking, and locating technology), the President of PerQFlo (combined insulin and pump to treat type 2 diabetes) and the Chief Executive Officer of NeuroSystec (combination drug-device to treat tinnitus). Mr. Goldberg served in executive management positions at Advanced Bionics Corporation, Los Angeles ...

Corporate Headquarters

355 Burrard Street
Vancouver, British Columbia V6C 2G8

Canada

Phone: 604-221-7676
Fax: 604-221-2330

Board Members Memberships

2011-Present
Co-Chairman of the Board and Chairman of Governance, Nominating & Compensation Committee

Education

There is no Education data available.

Other Affiliations

There is no Company Affiliations data available.

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Angiotech Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.